FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 20:37:00 24/05/2024 BST | ||
| 5.17 EUR | +2.78% |
|
| Current month | +27.65% | ||
| 1 month | +81.40% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 5.17 | +2.78% |
| 23/05/24 | 5.03 | +8.41% |
| 22/05/24 | 4.64 | -0.64% |
| 21/05/24 | 4.67 | +10.66% |
| 20/05/24 | 4.22 | +6.30% |
Delayed Quote Deutsche Boerse AG
Last update May 24, 2024 at 08:37 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SB0QYD |
| ISIN | DE000SB0QYD6 |
| Date issued | 04/06/2020 |
| Strike | 60.62 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 9.01 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.79 € |
|---|---|
| Lowest since issue | 0.63 € |
| Spread | 0.01 € |
| Spread % | 0.19% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.24
USD
Average target price
53.19
USD
Spread / Average Target
+28.99%
- Stock Market
- Certificates
- Certificat
